Global Budesonide Capsules market is expected to grow from US$ 1118 million in 2025 to US$ 1921 million in 2031; it is expected to grow at a CAGR of 9.4% from 2025 to 2031.

Global Budesonide Capsules Market Size and Outlook 2025-31

The global Budesonide Capsules market size is predicted to grow from US$ 1118 million in 2025 to US$ 1921 million in 2031; it is expected to grow at a CAGR of 9.4% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Budesonide is a first-line anti-inflammatory agent and locally acting glucocorticosteroid indicated for the induction and maintenance of remission of mild to moderate ileocaecal Crohns disease (capsules) and ulcerative colitis (enemas) as well as for the remission of active microscopic colitis (capsules). United States market for Budesonide Capsules is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Budesonide Capsules is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Budesonide Capsules is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Budesonide Capsules players cover Perrigo, Mylan, Tillotts Pharma, Teva, Zydus Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Budesonide Capsules Industry Forecast looks at past sales and reviews total world Budesonide Capsules sales in 2024, providing a comprehensive analysis by region and market sector of projected Budesonide Capsules sales for 2025 through 2031. With Budesonide Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Budesonide Capsules industry. This Insight Report provides a comprehensive analysis of the global Budesonide Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Budesonide Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Budesonide Capsules market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Budesonide Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Budesonide Capsules. This report presents a comprehensive overview, market shares, and growth opportunities of Budesonide Capsules market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; 1mg &nbsp;&nbsp;&nbsp; 2mg &nbsp;&nbsp;&nbsp; 3mg Segmentation by Application: &nbsp;&nbsp;&nbsp; Crohns Disease &nbsp;&nbsp;&nbsp; Collagenous Colitis &nbsp;&nbsp;&nbsp; Autoimmune Hepatitis This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Perrigo &nbsp;&nbsp;&nbsp; Mylan &nbsp;&nbsp;&nbsp; Tillotts Pharma &nbsp;&nbsp;&nbsp; Teva &nbsp;&nbsp;&nbsp; Zydus Pharmaceuticals &nbsp;&nbsp;&nbsp; Amneal &nbsp;&nbsp;&nbsp; Mayne Pharma &nbsp;&nbsp;&nbsp; Sciecure Pharma Key Questions Addressed in this Report What is the 10-year outlook for the global Budesonide Capsules market? What factors are driving Budesonide Capsules market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Budesonide Capsules market opportunities vary by end market size? How does Budesonide Capsules break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Budesonide Capsules Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Budesonide Capsules by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Budesonide Capsules by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Budesonide Capsules Segment by Type &nbsp;2.2.1 1mg &nbsp;2.2.2 2mg &nbsp;2.2.3 3mg &nbsp;2.3 Budesonide Capsules Sales by Type &nbsp;2.3.1 Global Budesonide Capsules Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Budesonide Capsules Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Budesonide Capsules Sale Price by Type (2020-2025) &nbsp;2.4 Budesonide Capsules Segment by Application &nbsp;2.4.1 Crohn's Disease &nbsp;2.4.2 Collagenous Colitis &nbsp;2.4.3 Autoimmune Hepatitis &nbsp;2.5 Budesonide Capsules Sales by Application &nbsp;2.5.1 Global Budesonide Capsules Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Budesonide Capsules Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Budesonide Capsules Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Budesonide Capsules Breakdown Data by Company &nbsp;3.1.1 Global Budesonide Capsules Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Budesonide Capsules Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Budesonide Capsules Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Budesonide Capsules Revenue by Company (2020-2025) &nbsp;3.2.2 Global Budesonide Capsules Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Budesonide Capsules Sale Price by Company &nbsp;3.4 Key Manufacturers Budesonide Capsules Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Budesonide Capsules Product Location Distribution &nbsp;3.4.2 Players Budesonide Capsules Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Budesonide Capsules by Geographic Region &nbsp;4.1 World Historic Budesonide Capsules Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Budesonide Capsules Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Budesonide Capsules Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Budesonide Capsules Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Budesonide Capsules Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Budesonide Capsules Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Budesonide Capsules Sales Growth &nbsp;4.4 APAC Budesonide Capsules Sales Growth &nbsp;4.5 Europe Budesonide Capsules Sales Growth &nbsp;4.6 Middle East & Africa Budesonide Capsules Sales Growth 5 Americas &nbsp;5.1 Americas Budesonide Capsules Sales by Country &nbsp;5.1.1 Americas Budesonide Capsules Sales by Country (2020-2025) &nbsp;5.1.2 Americas Budesonide Capsules Revenue by Country (2020-2025) &nbsp;5.2 Americas Budesonide Capsules Sales by Type (2020-2025) &nbsp;5.3 Americas Budesonide Capsules Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Budesonide Capsules Sales by Region &nbsp;6.1.1 APAC Budesonide Capsules Sales by Region (2020-2025) &nbsp;6.1.2 APAC Budesonide Capsules Revenue by Region (2020-2025) &nbsp;6.2 APAC Budesonide Capsules Sales by Type (2020-2025) &nbsp;6.3 APAC Budesonide Capsules Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Budesonide Capsules by Country &nbsp;7.1.1 Europe Budesonide Capsules Sales by Country (2020-2025) &nbsp;7.1.2 Europe Budesonide Capsules Revenue by Country (2020-2025) &nbsp;7.2 Europe Budesonide Capsules Sales by Type (2020-2025) &nbsp;7.3 Europe Budesonide Capsules Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Budesonide Capsules by Country &nbsp;8.1.1 Middle East & Africa Budesonide Capsules Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Budesonide Capsules Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Budesonide Capsules Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Budesonide Capsules Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Budesonide Capsules &nbsp;10.3 Manufacturing Process Analysis of Budesonide Capsules &nbsp;10.4 Industry Chain Structure of Budesonide Capsules 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Budesonide Capsules Distributors &nbsp;11.3 Budesonide Capsules Customer 12 World Forecast Review for Budesonide Capsules by Geographic Region &nbsp;12.1 Global Budesonide Capsules Market Size Forecast by Region &nbsp;12.1.1 Global Budesonide Capsules Forecast by Region (2026-2031) &nbsp;12.1.2 Global Budesonide Capsules Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Budesonide Capsules Forecast by Type (2026-2031) &nbsp;12.7 Global Budesonide Capsules Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Perrigo &nbsp;13.1.1 Perrigo Company Information &nbsp;13.1.2 Perrigo Budesonide Capsules Product Portfolios and Specifications &nbsp;13.1.3 Perrigo Budesonide Capsules Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Perrigo Main Business Overview &nbsp;13.1.5 Perrigo Latest Developments &nbsp;13.2 Mylan &nbsp;13.2.1 Mylan Company Information &nbsp;13.2.2 Mylan Budesonide Capsules Product Portfolios and Specifications &nbsp;13.2.3 Mylan Budesonide Capsules Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Mylan Main Business Overview &nbsp;13.2.5 Mylan Latest Developments &nbsp;13.3 Tillotts Pharma &nbsp;13.3.1 Tillotts Pharma Company Information &nbsp;13.3.2 Tillotts Pharma Budesonide Capsules Product Portfolios and Specifications &nbsp;13.3.3 Tillotts Pharma Budesonide Capsules Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Tillotts Pharma Main Business Overview &nbsp;13.3.5 Tillotts Pharma Latest Developments &nbsp;13.4 Teva &nbsp;13.4.1 Teva Company Information &nbsp;13.4.2 Teva Budesonide Capsules Product Portfolios and Specifications &nbsp;13.4.3 Teva Budesonide Capsules Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Teva Main Business Overview &nbsp;13.4.5 Teva Latest Developments &nbsp;13.5 Zydus Pharmaceuticals &nbsp;13.5.1 Zydus Pharmaceuticals Company Information &nbsp;13.5.2 Zydus Pharmaceuticals Budesonide Capsules Product Portfolios and Specifications &nbsp;13.5.3 Zydus Pharmaceuticals Budesonide Capsules Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Zydus Pharmaceuticals Main Business Overview &nbsp;13.5.5 Zydus Pharmaceuticals Latest Developments &nbsp;13.6 Amneal &nbsp;13.6.1 Amneal Company Information &nbsp;13.6.2 Amneal Budesonide Capsules Product Portfolios and Specifications &nbsp;13.6.3 Amneal Budesonide Capsules Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Amneal Main Business Overview &nbsp;13.6.5 Amneal Latest Developments &nbsp;13.7 Mayne Pharma &nbsp;13.7.1 Mayne Pharma Company Information &nbsp;13.7.2 Mayne Pharma Budesonide Capsules Product Portfolios and Specifications &nbsp;13.7.3 Mayne Pharma Budesonide Capsules Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Mayne Pharma Main Business Overview &nbsp;13.7.5 Mayne Pharma Latest Developments &nbsp;13.8 Sciecure Pharma &nbsp;13.8.1 Sciecure Pharma Company Information &nbsp;13.8.2 Sciecure Pharma Budesonide Capsules Product Portfolios and Specifications &nbsp;13.8.3 Sciecure Pharma Budesonide Capsules Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Sciecure Pharma Main Business Overview &nbsp;13.8.5 Sciecure Pharma Latest Developments 14 Research Findings and Conclusion

Report	Global Budesonide Capsules Market Growth 2025-2031
Selected License	Multi ID: LPI25062

Buyer Information

Order Summary